When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Before this report, I have written two other Seeking Alpha reports about Acasti Pharma (ACST) in 2019, espousing ACST’s profound market opportunity and its leading drug CaPre’s competitive advantages; my first report in June was published when the stock was only $1.01/share. Yesterday, ACST closed at $2.08/share, demonstrating a 106% return in 5 months, since my first report. While the stock has made some progress, it has a long way to go, and from the second report (please see article below for valuation section), the price target of $11.06/share may prove conservative,